In First, Aging Stopped in Humans: Tel Aviv University Co-Study
TEL AVIV, Israel, Nov. 23 (TNSRes) -- Tel Aviv University issued the following news on Nov. 22:
A first-of-its-kind clinical trial in human subjects: A new study from Tel Aviv University and the Shamir Medical Center indicates that HBOT (treatments with high-pressure oxygen) in healthy aging adults can stop the aging of blood cells.
The researchers found that a unique protocol of treatments in a pressure chamber can reverse two major processes associated with aging and . . .
A first-of-its-kind clinical trial in human subjects: A new study from Tel Aviv University and the Shamir Medical Center indicates that HBOT (treatments with high-pressure oxygen) in healthy aging adults can stop the aging of blood cells.
The researchers found that a unique protocol of treatments in a pressure chamber can reverse two major processes associated with aging and . . .